The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Viewing education differently: A novel educational approach using virtual tumor board cases.
 
John R Ogden
Consulting or Advisory Role - PrecisCa
 
Mohit Shiv Agarwal
Consulting or Advisory Role - Precisca
 
Lauren Chiec
Honoraria - MJH Life Sciences
Consulting or Advisory Role - Precisca
 
Erin Shonkwiler
Employment - University of Kansas Health System
Honoraria - Precisca
Consulting or Advisory Role - Precisca
 
Michael Chaby
Leadership - Precisca
Consulting or Advisory Role - Precisca
 
Naomi Dempsey
Leadership - Precisca
Consulting or Advisory Role - Precisca
 
Michael J. Pishvaian
Stock and Other Ownership Interests - Perthera
Honoraria - Halozyme
Consulting or Advisory Role - AstraZeneca/MedImmune; Foundation Medicine; Merck; Novartis; Perthera; Pfizer
Research Funding - Arcus Biosciences (Inst); Pfizer (Inst); Seagen (Inst); Tesaro (Inst)
Patents, Royalties, Other Intellectual Property - Perthera patient matching algorithm; Use patent for veliparib and FOLFOX
 
Samuel J Klempner
Stock and Other Ownership Interests - TP Therapeutics
Honoraria - Natera
Consulting or Advisory Role - Astellas Pharma; Boston Biomedical; Bristol-Myers Squibb; Daiichi Sankyo/UCB Japan; Foundation Medicine; Lilly; Merck; Pieris Pharmaceuticals
Speakers' Bureau - Foundation Medicine
Research Funding - BeiGene (Inst); Leap Therapeutics (Inst)
Other Relationship - NCCN
 
Al Bowen Benson
Consulting or Advisory Role - Abbvie; Apexigen; Array BioPharma; Artemida Pharma; Boston Scientific; Bristol-Myers Squibb; HalioDx; Janssen Oncology; Merck Sharp & Dohme; Mirati Therapeutics; Natera; Pfizer; Samsung Bioepis; Therabionic; Xencor
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Elevar Therapeutics (Inst); Infinity Pharmaceuticals (Inst); ITM Solucin (Inst); MedImmune (Inst); Merck Sharp & Dohme (Inst); Rafael Pharmaceuticals (Inst); st pharm (Inst); SynCoreBio (Inst); Taiho Pharmaceutical (Inst); Tyme Inc (Inst); Xencor (Inst)
 
Christopher Hanyoung Lieu
Consulting or Advisory Role - HalioDx (Inst); Ipsen (Inst); Pfizer (Inst)
Research Funding - Merck (Inst)
 
Mohammad Jahanzeb
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Immunomedics; Lilly; Merck; Novartis; Pfizer; Puma Biotechnology; Roche/Genentech; Seagen; Takeda
Speakers' Bureau - AstraZeneca; Immunomedics; Merck; Novartis; Pfizer; Seagen
Research Funding - Abbvie (Inst); Boehringer Ingelheim (Inst); Callisto Pharmaceuticals (Inst); Genentech/Roche (Inst); Ipsen (Inst); Lilly (Inst); Morphotek (Inst); Novartis (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Amgen; Immunomedics; Merck; Novartis; takeda